Table 1 Patient, tumor, and treatment characteristics at initial planning (CT0)
From: A Nomogram to predict parotid gland overdose in head and neck IMRT
ID | Gender | Age | TNM | Tumor sublocation | Chemotherapy | Volume (cm3) | Mean planned PG dose (Gy) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CTV70 | ILP | CLP | ILP | CLP | ILP | CLP | ||||||
1 | M | 77 | T4N0 | Tonsil | Cetuximab | 45.2 | 52.1 | 48.6 | 30.2 | 31.1 | 27.1 | 28.9 |
2 | F | 61 | T2N2 | Base of tongue | CDDP | 26.3 | 31.1 | 27.5 | 31.4 | 26 | 29.7 | 19.1 |
3 | M | 70 | T3N2c | Oropharynx | CDDP | 181.5 | 24.9 | 20.7 | 37.9 | 31.1 | 45.1 | 29.1 |
4 | F | 66 | T2N2c | Oropharynx | Cetuximab | 107.2 | 27.8 | 23.4 | 32.9 | 27.9 | 33.1 | 22.5 |
5 | M | 57 | T3N0 | Velum | CDDP | 62.4 | 20.7 | 18 | 28.1 | 27.8 | 23 | 22.3 |
6 | M | 67 | T3N2c | Base of tongue | CDDP | 156.2 | 24.5 | 22.7 | 30.8 | 29.4 | 25.4 | 22.1 |
7 | M | 52 | T4N2a | Tonsil | Cetuximab | 165.1 | N/A | 21.6 | N/A | 28.7 | N/A | 24 |
8 | M | 67 | T4N1 | Base of tongue | CDDP | 139.3 | 22 | 19.3 | 30.7 | 29.2 | 28 | 25 |
9 | F | 65 | T3N3 | Base of tongue | CDDP | 237.5 | 23.9 | 20.2 | 42.4 | 31.1 | 56.1 | 29 |
10 | F | 65 | T4N3 | Oropharynx | CDDP | 257.9 | N/A | 24.5 | N/A | 35.2 | N/A | 38.5 |
11 | M | 50 | T4N2c | Oropharynx | CDDP | 434.5 | N/A | 17.7 | N/A | 36.3 | N/A | 41.1 |
12 | M | 53 | T3N0 | Base of tongue | CDDP | 14.4 | 16.6 | 23.3 | 41.3 | 24.2 | 53.6 | 16.3 |
13 | M | 73 | T3N2c | Oropharynx | Cetuximab | 147 | 29.4 | 29.2 | 54.6 | 32.2 | 82.1 | 31.4 |
14 | M | 56 | T3N0 | Epiglottic | Cetuximab | 14 | 22.8 | 29.2 | 19.7 | 9.2 | 10.3 | 2.7 |
15 | M | 75 | T2N2a | Oropharynx | Cetuximab | 76.3 | 20.3 | 22.4 | 29.4 | 29.1 | 25.6 | 25 |
16 | M | 57 | T3N0 | Oropharynx | CDDP | 46.5 | 23.8 | 31.2 | 32.1 | 31.2 | 29.3 | 31.3 |
17 | M | 64 | T3N2c | Epiglottic | CDDP | 109.8 | 23.5 | 15.6 | 39.6 | 17.3 | 49.3 | 7.8 |
18 | M | 55 | T1N2b | Tonsil | CDDP | 31 | 20.2 | 20.8 | 25.7 | 23.63 | 18.7 | 15.3 |
19 | M | 65 | T4N0 | Velum | CDDP | 10.1 | 23.7 | 25.3 | 28.6 | 28.2 | 24 | 23.2 |
20 | M | 56 | T4N2b | Pharyngeal wall | CDDP | 150 | 32.4 | 26.8 | 45 | 24.4 | 62.8 | 16.6 |